Abstract
CYP2C19 is an important member of the cytochrome P-450 enzyme superfamily and plays a significant role in the drug metabolism. In order to gain insights for developing personalized drugs, the structure-activity relationships of two SNPs, W120R and I331V, with the ligands of CEC, Fluvoxamine, Lescol and Ticlopidine were investigated through the structure-activity relationship approach. By means of a series of docking studies, the binding pockets of the two SNPs for the four compounds are explicitly defined that will be very useful for conducting mutagenesis studies, providing insights into personalization of drug treatments and stimulating novel strategies for finding desired personalized drugs.
Keywords: CYP2C19, Cytochrome P-450, Structure-activity relationship, CEC, Fluvoxamine, Lescol, Ticlopidine, Personalized drug design
Protein & Peptide Letters
Title: Molecular Modeling of Two CYP2C19 SNPs and Its Implications for Personalized Drug Design
Volume: 15 Issue: 1
Author(s): Dong-Qing Wei, Jing-Fang Wang, Chao Chen, Yixue Li and Kuo-Chen Chou
Affiliation:
Keywords: CYP2C19, Cytochrome P-450, Structure-activity relationship, CEC, Fluvoxamine, Lescol, Ticlopidine, Personalized drug design
Abstract: CYP2C19 is an important member of the cytochrome P-450 enzyme superfamily and plays a significant role in the drug metabolism. In order to gain insights for developing personalized drugs, the structure-activity relationships of two SNPs, W120R and I331V, with the ligands of CEC, Fluvoxamine, Lescol and Ticlopidine were investigated through the structure-activity relationship approach. By means of a series of docking studies, the binding pockets of the two SNPs for the four compounds are explicitly defined that will be very useful for conducting mutagenesis studies, providing insights into personalization of drug treatments and stimulating novel strategies for finding desired personalized drugs.
Export Options
About this article
Cite this article as:
Wei Dong-Qing, Wang Jing-Fang, Chen Chao, Li Yixue and Chou Kuo-Chen, Molecular Modeling of Two CYP2C19 SNPs and Its Implications for Personalized Drug Design, Protein & Peptide Letters 2008; 15 (1) . https://dx.doi.org/10.2174/092986608783330305
DOI https://dx.doi.org/10.2174/092986608783330305 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Meet Our Editorial Board Member
Current Nutrition & Food Science Synthesis and Screening of Substituted Thiosemicarbazone Derivatives: An Approach towards Novel Anticonvulsant Search
Central Nervous System Agents in Medicinal Chemistry The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise
Current Molecular Medicine Current Overviews on COVID-19 Management Strategies
Current Pharmaceutical Biotechnology An Overview of Neolignans of the Genus Piper L.: Isolation Methods and Biological Activities
Mini-Reviews in Medicinal Chemistry Computational Methods to Predict Drug Safety
Current Computer-Aided Drug Design Evaluating the Potential of <i>Adathoda vasica</i> against Respiratory Infection caused by <i>Klebsiella pneumoniae</i>
Current Chinese Science Therapeutic Monitoring of Plasma Digoxin for COVID-19 Patients Using a Simple UPLC-MS/MS Method
Current Pharmaceutical Analysis Subacute Thyroiditis Post-COVID-19 Infection: A Case Report
New Emirates Medical Journal The Patents on Glucocorticosteroids and Selected New Therapies for the Management of Asthma in Children
Recent Patents on Inflammation & Allergy Drug Discovery SARS-CoV-2 Kerala Isolate Spike Protein Induces Cancer Proliferating Markers for Lung and Breast Cancer: An <i>In Silico</i> Approach
Coronaviruses Polyphenols: Biological Activities, Molecular Targets, and the Effect of Methylation
Current Molecular Pharmacology <i>In-silico</i> Studies and Biological Activity of Potential BACE-1 Inhibitors
Combinatorial Chemistry & High Throughput Screening Most Recent Developments and Modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan Derivatives
Mini-Reviews in Medicinal Chemistry COVID-19: A Review on Epidemiology, Clinical Features and Possible Potential Drugs Based on Available Case Studies
Coronaviruses Probiotics for the Prevention and Treatment of Allergies, with an Emphasis on Mode of Delivery and Mechanism of Action
Current Pharmaceutical Design Future Perspectives in the Pharmacological Treatment of Atrial Fibrillation and Ventricular Arrhythmias in Heart Failure
Current Pharmaceutical Design Gene Therapy Cargoes Based on Viral Vector Delivery
Current Gene Therapy Current Management of Neonatal Liver Tumors
Current Pediatric Reviews Computer-Aided Drug Design: Lead Discovery and Optimization
Combinatorial Chemistry & High Throughput Screening